Matthew Davis PhD joined Gritstone Bio (NASDAQ: GRTS) in 2015 and is currently the Senior Director of Molecular Biology and Sequencing responsible for various neoantigen discovery and translational genomics efforts. Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group. He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and before his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.